Bayesian forecasting in paediatric populations

Clinical Pharmacokinetics

Volumn 31, Issue 5, 1996, Pages 325-330

  Fernández De Gatta, Ma Del Mar ^a   García, Ma José ^a   Lanao, José M ^a   Domínguez Gil, Alfonso ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; IMIPRAMINE; PHENYTOIN; THEOPHYLLINE; VANCOMYCIN;

BAYES THEOREM; COMPUTER PROGRAM; DOSE CALCULATION; FORECASTING; METHODOLOGY; PHARMACOKINETICS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029862565     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199631050-00001     Document Type: Short Survey

References (59)

1. Sheiner LB, Beal SL, Rosemberg B, et al. Forecasting individual pharmacokinetics. Clin Pharmacol Ther 1979 Sep; 26: 294-305
2. Peck CC, Brown WD, Sheiner LB, et al. A microcomputer drug (theophylline) dosing program which assists and teaches physicians. Proceedings of the 4th Annual Conference on Computers and Medical Care, New York: IEEE Computer Society Publications Office, 1980: 988-94
3. Buffington DE, Lampasona V, Chandler MHH. Computers in pharmacokinetics: choosing software for clinical decision making. Clin Pharmacokinet 1993 Sep; 25 (3): 205-16
4. Thomson AH, Whiting B. Bayesian parameter estimation and population pharmacokinetics. Clin Pharmacokinet 1992 Jun; 22 (6): 447-67
5. Pryka RD, Rodvold KA, Erdman SM. An updated comparison of drug dosing methods (Pt I): phenytoin. Clin Pharmacokinet 1991 Mar; 20 (3): 209-17
6. Erdman SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods (Pt II): theophylline. Clin Pharmacokinet 1991 Apr; 20 (4): 280-92
7. Erdman SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods (Pt III): aminoglycoside antibiotics. Clin Pharmacokinet 1991 May; 20 (5): 374-88
8. Pryka RD, Rodvold KA, Erdman SM. An updated comparison of drug dosing methods (Pt IV): vancomycin. Clin Pharmacokinet 1991 Jun; 20 (6): 463-76
9. Morselli PL. Clinical pharmacology of the perinatal period and early infancy. Clin Pharmacokinet 1989; 17 Suppl. 1: 13-28
10. Vozeh S, Steiner C. Estimates of the population pharmacokinetic parameters and performance of buyesian feedback: a sensitivity analysis. J Pharmacokinet Biopharm 1987; 15: 511-28
11. Gilman JT. Therapeutic drug monitoring in the neonate and pediatric age group: problems and clinical pharmacokinetic implications. Clin Pharmacokinet 1990 Jan; 19 (1): 1-10
12. Jelliffe RW, Schumitzky A, Van Guilder M. et al. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, bayesian fitting, and adaptative control. Ther Drug Monit 1993 Oct; 15 (5): 380-93
13. Proost JH. Adaptative control of drug dosage regimens using maximum a posteriori probability Bayesian fitting, Int J Clin Pharmacol Ther 1995 Oct; 33 (10): 531-6
14. Kraus DM, Dusik CM, Rodvold KA, et al. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients. Pediatr Infect Dis J 1993 Sep: 12 (9): 713-18
15. Yukawa E, Higuchi S, Aoyama T. Evaluation of single-point phenytoin dosage prediction methods in pediatric patients. J Pharmacobiodyn 1988 Nov; 11: 736-43
16. Yuen GJ, Latimer PT, Littlefiel C, et al. Phenytoin dosage predictions in paediatric patients. Clin Pharmacokinet 1989 Apr; 16 (4): 254-60
17. Lui K, Brysson SM, Irwin DB, et al. Evaluation of bayesian forecasting for individualized gentamicin dosage in infants weighing 1.000g. or less. Am J Dis Child 1991 Apr; 145 (4): 463-7
18. Chang D, Liem L, Malogolowkin M. A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients. Pediatr Infect Dis J 1994 Nov; 13 (11): 969-74
19. Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface (Pt I). Clin Pharmacokinet 1988 Apr; 14 (4): 189-216
20. Besunder JB, Reed D, Blumer JL. Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface (Pt II). Clin Pharmacokinet 1988 May; 14 (5): 261-86
21. Gilman JT, Gal P. Pharmacokinetic and pharmacodynamic data collection in children and neonates: a quiet frontier. Clin Pharmacokinet 1992 Jul; 23 (1): 1-9
22. Kauffman RE, Kearns GL. Pharmacokinetic studies in paediatric patients.: clinical and ethical considerations. Clin Pharmacokinet 1992 Jul; 23 (1): 10-29
23. Wilson JT, Kearns GL, Murphy D, et al. Paediatric labelling requirements: implications for pharmacokinetic studies. Clin Pharmacokinet 1994 Apr; 26 (4): 308-25
24. Sheiner LB, Beal SL. Evaluation of methods for estimating population characteristics of pharmacokinetic parameters III, monoexponential model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm 1983; 11: 303-19
25. Grasela Jr TH, Antal EJ, Townsend RJ, et al. An evaluation of population pharmacokinetics in therapeutic trials part I: comparison of methodologies. Clin Pharmacol Ther 1986 Jun; 39 (6): 605-12
26. Ebling WF, Maitre PO, Stanski DR. A comparison of NONMEM versus two-stage pharmacokinetic analysis [abstract]. Clin Pharmacol Ther 1988 Feb; 43 (2): 132
27. Collart L, Blaschke TF, Boucher F, et al. Potential of population pharmacokinetics to reduce the frequency of blood sampling required for estimating kinetic parameters in neonates. Dev Pharmacol Ther 1992; 18: 77-80
28. Moore ES, Faix RG, Banagale RC, et al. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm 1989 Feb; 17 (1): 47-66
29. Martin SE. The population pharmacokinetics of theophylline during the early postnatal period. J Pharmacokinet Biopharm 1991; 19 (3 Suppl.): 59S-77S
30. Fattinger K, Vozeh S, Olafsson A, et al. Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations. Clin Pharmacol Ther 1991 Jul; 50: 55-65
31. Seay RE, Brundage RC, Jensen PD, et al. Population pharmacokineties of vancomycin in neonates. Clin Pharmacol Ther 1994 Aug; 56 (2): 169-75
32. Parker EM, Hutchison M, Blumer JL. The pharmacokinetics of meropenem in infants and children: a population analysis. J Antimicrob Chemother 1995 Jul; 36 (A Suppl.): 63-71
33. Botha JH, Gray AL, Miller R. Determination of phenobarbitone population clearance values for South African children. Eur J Clin Pharmacol 1995; 48 (5): 381-3
34. Padovani EM, Pistolesi C, Fanos V, et al. Pharmacokinetics of amikacin in neonates. Dev Pharmacol Ther 1993; 20: 167-73
35. Bauer LA, Blenin RA. Phenytoin Michaelis-Menten pharmacokinetics in caucasian paediatric patients. Clin Pharmacokinet 1983; 8 (6): 545-49
36. Rodvold KA, Gentry CA, Plank G, et al. Bayesian forecasting of serum vancomycin concentrations in neonates and infants. Ther Drug Monit 1995 Jun; 17 (3): 239-46
37. Rodvold KA, Gentry CA, Plank G, et al. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model. Dev Pharmacol Ther 1993; 20: 211-19
38. Dodge W, Jelliffe R, Richardson J, et al. Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method. Clin Pharmacol Ther 1991 Jul; 50: 25-31
39. Steimer JL, Vozeh S, Racine-Poon A, et al. The population approach: rationale, methods, and applications in clinical pharmacology and drug development. In: Welling PG, Balant LC, editors. Pharmacokinetics of drugs. Berlin: Springer-Verlag, 1994: 405-51
40. Poirier TI, Giudici R. Survey of clinical pharmacokinetic software for microcomputers. Hosp Pharm 1992 Nov; 27: 971-77
41. Robinson JD. Simkin pharmacokinetics system user manual. Gainsville (FL): Simkin, 1990
42. Ordovas Baines JP, Jiménez Torres NV. Monitoring of antiepileptic agents in pediatric patient: development of a Bayesian computer application (EPIBAYES). Farm Hosp 1993 Mar-Apr; 17 (2): 81-7
43. Kelman AW, Whiting B, Bryson SM. OPT: a package of computer programs for parameter optimization in clinical pharmacokinetics. Br J Clin Pharmacol 1982 Aug; 14: 247-56
44. Abbottbase Pharmacokinetic System. Illinois: Abbott Laboratories, Diagnostics Division Abbott Park, 1991
45. Burton ME, Brater DC, Chen PS, et al. A Bayesian feedback method of aminoglycoside dosing. Clin Pharmacol Ther 1985 Mar; 37: 349-57
46. Brater DC, Day RB. Theophyline dosing program-version 3.1. Indianapolis: Indiana/Purdue Universities at Indianapolis, 1987
47. D'Argenio D, Schumitzky A. A user's guide to the ADAPT programs. Los Angeles: Laboratory of Applied Pharmacokinetics, University of Southern California, 1979
48. Higuchi S, Aoyama T, Horioka M. PEDA: A microcomputer program for parameter estimation and dosage adjustment in clinical practice. J Pharmacobiodyn 1987 Dec; 10: 703-18
49. Anderson PO. TDMS program user manual. San Diego (CA): Healthware, 1988
50. Yamaoka K, Nakagowa T, Tanaka H, et al. A non linear multiple regression program, MULTI2 (BAYES) based on Bayesian algorithm for microcomputers. J Pharmacobiodyn 1985 Jun; 8: 246-56
51. Jeliffe R, D'Argenio D, Schumitzky A, et al. The USC PC PACK programs for planning, monitoring and adjusting drug dosage regimens. Proceedings of the 23rd Annual Meeting of the Association for the Advancement of Medical Instrumentation: 1988 May 14-19; Washington, DC, 51
52. Kelman AW, Thomson AH, Whiting B, et al. Estimation of gentamicin clearance and volume of distribution in neonates and young children. Br J Clin Pharmacol 1984 Nov; 18: 685-92
53. Carlstedt BC, Uaamnuichai M, Day RB, et al. Aminoglycoside dosing in pediatric patients. Ther Drug Monit 1989 Jan; 11: 38-43
54. Murphy MG, Peck CC, Merenstein GB, et al. An evaluation of Bayesian microcomputer predictions of theophylline concentrations in newborn infants. Ther Drug Monit 1990 Jan; 12: 47-53
55. Steinberg I, Gilman TM. Literature versus institution prior & Bayesian methods for prediction of theophylline concentrations in pediatric patients [abstract]. Clin Pharmacol Ther 1990 Feb; (2): 186
56. Godley PJ, Karboski JA, Godley SE, et al. Evaluation of three theophylline dosing methods in pediatric patients. DICP Ann Pharmacother 1991 Feb; 25: 179-85
57. Tamayo M, Fernández de Gatta MM, García MJ, et al. Dosage optimization methods applied to imipramine and desipramine in enuresis treatment. J Clin Pharm Ther 1992 Feb; 17 (2): 55-9
58. Rodman JH, Sunderland M, Kavanagh RL, et al. Pharmacokinetics of continous infusion of methotrexate and teniposide in pediatric cancer patients. Cancer Res 1990 Jul; 50 (7): 4267-71
59. Whiting B, Kelman AW, Grevel J. Population pharmacokinetics: theory and clinical application. Clin Pharmacokinet 1986 Nov; 11: 387-401